Digital Pathology Market Size, Share & Trends Analysis Report By Product (Software, Device), By Application (Drug Discovery & Development, Academic Research), By End-use, By Region, And Segment Forecasts, 2021 - 2028

Report Overview

The global digital pathology market size was valued at USD 882.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2021 to 2028. Increased focus on improving workflow efficiency and demand for faster diagnostic tools for chronic diseases, such as cancer, have been key factors driving the growth. The rising prevalence of chronic conditions is anticipated to surge clinical urgency to adopt digital pathology to improve existing poor patient diagnostic imaging measures and to reduce high costs associated with conventional diagnostics.

During COVID-19, the U.S. FDA’s Center for Devices and Radiological Health released an enforcement policy for remote digital pathology devices intended for pathologists, industry, clinical laboratories, drug administration staff, and healthcare facilities. The document provides a policy framework to expand the availability of remote digital pathology devices during the pandemic. Supportive regulations are anticipated to impact the market in a positive way in the coming few years.

Rapid technological advancements in digital pathology systems are expected to contribute to market growth. Advancements such as digital imaging, computerization, robotic light microscopy, and multiple fiber optic communications are also contributing to the growth. Whole slide imaging is one such technique that has various advantages over conventional light microscopes, which is expected to provide this market with lucrative opportunities in the forthcoming years.

此外,诸如微阵列和进步the incorporation of a wide range of predictive models such as hybrid models and API algorithms are expected to fuel demand for digital image analysis. Rising preference for computer-aided diagnosis that integrates image processing, physics, mathematics, and computing algorithms, facilitates efficient disease detection and helps evaluate anatomic structures of interest and quantification of disease progression as well as risk assessment. These benefits are expected to fuel the demand for digital pathology systems in the near future.

The novel coronavirus is having a significant economic impact on most sectors, including the healthcare industry. Government bodies all over the world are responding to the threat of COVID-19 with essential measures, such as nationwide lockdowns, social distancing, and large-scale quarantine to reduce the spread of the virus. The pandemic created a major growth opportunity for digital pathology. On March 26, 2020, CMS waived off the stringent regulation pertinent to remote diagnosis temporarily and allowed remote sign-out of pathology cases using digital pathology equipment.

The Digi path companies such as Olympus, Phillips, and Leica are offering a wide range of tools for remote slide sharing and image processing which is expected to increase the adoption over the coming years. In April 2020, Leica Biosystems received US FDA approval for Aperio AT2 DX Scanner and Aperio WebViewer for remote diagnosis during the pandemic. Moreover, Phillips also received USFDA clearance for its IntelliSite Pathology Solution for remote diagnosis during this emergency.

Product爱游戏ayx电子竞技

The device segment dominated the market for digital pathology and accounted for the largest revenue share of 52.0% in 2020. The devices include scanner and slide management systems. The rise in academic research activities and enhanced resolution are the key growth drivers. This technology is expected to witness lucrative growth over the forecast period owing to advancements in magnification and scanning of slides at the Z-axis, which is offered by whole slide imaging.

Moreover, the increased use of scanners in pathology labs is further fueling the market growth. Increasing R&D pertaining to applications such as slide managers is expected to boost the adoption of this technology in the near future. Increasing demand for an online storage system is further fueling the growth. The advantages such as cost reduction improved productivity, and better patient outcomes coupled with data reliability and Image Lifecycle Management (ILM) are expected to drive the market.

Application Insights

The academic research segment led the market for digital pathology and accounted for the largest revenue share of 45.7% in 2020. This growth is owing to wide applications of the systems in various research procedures such as biomarker profiling and tumor morphological study. The disease diagnosis segment is expected to witness the fastest CAGR of 7.0% over the forecast period due to the increasing prevalence of chronic diseases. In addition, the focus of the manufacturers on the development of novel and rapid diagnostic techniques. Digital technologies help in improving each step in diagnostic and easy to share information within inter or intra-departments. The cancer cell detection segment is expected to showcase lucrative growth in the disease diagnosis segment over the forecast period owing to the high prevalence of the disease coupled with ongoing research initiatives.

End-use Insights

The hospitals' segment dominated the market for digital pathology and accounted for the largest revenue share of 36.2% in 2020, owing to the increasing adoption of these techniques. Hospitals are adopting digital scanning techniques for faster diagnosis and better patient compliance.

The biotech and pharma companies segment is expected to exhibit steady growth over the forecast period. The growth is attributed to the increased use of digital pathology in drug development,oncology clinical trials, and preclinical GLP pathology. The increasing prevalence of cancer and the demand for better treatment options is anticipated to further fuel the market over the forecast period.

Regional Insights

2020年,北美数字patho主导logy market and held the largest revenue share of over 40.0%. Continual deployment of R&D investments, supportive government initiatives pertaining to the development of technologically advanced systems, rising adoption of digital imaging, and the presence of major players are the key contributing factors for this dominance. Increased usage of digital pathology for disease diagnosis coupled with favorable reimbursement policies in the U.S., improving the quality of cancer diagnosis, is expected to further fuel the regional growth.

In Asia Pacific, the market for digital pathology is expected to expand at a CAGR of 7.3% during the forecast period due to the rising penetration of digital imaging in emerging economies, investments in the medical field, and the presence of untapped opportunities. Asia Pacific healthcare industry has highly influenced the market due to the increased incidence of cancer, which affects a large population. Also, increasing demand for novel treatment options, better patient care facilities, and reduction in laboratory expenses are expected to further drive the demand.

Key Companies & Market Share Insights

Major players, such as Danaher; Hamamatsu Photonics, Inc.; held a dominant market share in 2020. These companies are increasingly undertaking new product developments, extensive collaborative strategies, and mergers and acquisitions to gain more profits. For example, In August 2020, Danaher launched Aperio GT 450 DX in Europe, and in the month of May, this product was launched in the Asia Pacific. These strategic product launches in new geographies are aimed at enhancing companies’ regional footprint.

The other key participant Koninklijke Philips N.V.. in September 2020, helped 100% digitization of histology slides at Oxford University Hospitals Cellular Pathology department. Moreover, in June 2018, acquired the Irish PathXL, one of the largest pathology image-based analysis firms. This acquisition was carried out to develop integrated tools targeting applications in computational biology, workflow solutions, education, and image analytics.

This acquisition is aimed at underpinning the gradual transition of medical institutions present across the globe from the traditional systems to digitized pathology systems. Thus, the acquisition will further enable pathologists to perform high-throughput analysis of colossal clinical image datasets that are diverse in nature and facilitate improvement in the diagnosis quality, thereby presenting a potential for inclusion of new therapies to enhance patient health outcomes. Some of the prominent players in the digital pathology market include:

• Danaher

• Hamamatsu Photonics, Inc.

• Koninklijke Philips N.V.

• Olympus Corporation

• F. Hoffmann-La Roche Ltd.

• Mikroscan Technologies

• Inspirata, Inc.

• Visiopharm A/S

• Huron Digital Pathology

• 3DHISTECH Ltd.

• ContextVision AB.

Digital PathologyMarket Report Scope

Report Attribute	Details
Market size value in 2021	USD 926.9 million
Revenue forecast in 2028	USD 1,464.4 million
Growth Rate	CAGR of 6.8% from 2021 to 2028
Base year for estimation	2020
Historical data	2016 - 2019
Forecast period	2021 - 2028
Quantitative units	Revenue in USD million and CAGR from 2021 to 2028
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Product, application, end-use, region
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country Scope	U.S.; Canada; U.K.; Germany; Italy; France; Russia; Spain; Netherlands; Switzerland; Sweden; Japan; China; India; Indonesia; Thailand; Australia; South Korea; Philippines; Malaysia; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; Turkey; Iran; UAE; Israel
Key companies profiled	Danaher; Hamamatsu Photonics, Inc; Koninklijke Philips N.V.; Olympus Corporation; F. Hoffmann-La Roche Ltd; Mikroscan Technologies; Inspirata, Inc; Visiopharm A/S; Huron Digital Pathology; 3DHISTECH Ltd.; ContextVision AB
Customization scope	Free report customization (equivalent to up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this report, Grand View Research has segmented the global digital pathology market report on the basis of product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Software

  • Device

  • Storage System

• Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Drug Discovery & Development

  • Academic research

  • Disease Diagnosis

• End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals

  • Biotech & pharma companies

  • Diagnostic Labs

  • Academic & research institutes

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Sweden

  • Asia Pacific

    • Japan

    • China

    • India

    • Indonesia

    • Thailand

    • Australia

    • South Korea

    • Philippines

    • Malaysia

    • Singapore

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • Turkey

    • Iran

    • United Arab Emirates

    • Israel